Загрузка...
Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt vs. Deferred Laser Treatment: 5-year Randomized Trial Results
OBJECTIVE: To report 5-year results from a previously reported trial evaluating intravitreal 0.5-mg ranibizumab with prompt versus deferred (for ≥24 weeks) focal/grid laser treatment for diabetic macular edema (DME). DESIGN: Multicenter randomized clinical trial. PARTICIPANTS: Among participants fro...
Сохранить в:
| Опубликовано в: : | Ophthalmology |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4520307/ https://ncbi.nlm.nih.gov/pubmed/25439614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2014.08.047 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|